Literature DB >> 20610311

ISFM and AAFP consensus guidelines: long-term use of NSAIDs in cats.

Andrew H Sparkes, Reidun Heiene, B Duncan X Lascelles, Richard Malik, Llibertat Real Sampietro, Sheilah Robertson, Margie Scherk, Polly Taylor.   

Abstract

UNLABELLED: NSAIDS AND CATS: Non-steroidal anti-inflammatory drugs (NSAIDs) are an important class of drug in feline medicine, having analgesic, anti-inflammatory and antipyretic activity. While most published data on their use in this species relate to short-term (often perioperative) therapy, there is increasing evidence of the value of these drugs in treating chronic pain in cats (for example, that associated with degenerative joint disease), and some NSAIDs have now become licensed for long-term use in cats in some geographies. Most of our knowledge of therapeutic mechanisms or adverse drug reactions associated with NSAIDs is extrapolated from work in other species, and there is a paucity of published data relating to cats. GUIDELINES: These guidelines have been drawn together by an expert panel, which have reviewed the current literature on long-term NSAID use in cats and other species, and developed guidance on their use based on this information. The aim is to provide practical information for veterinarians to encourage appropriate NSAID therapy whenever cats will benefit from the use of these drugs. Copyright 2010 ISFM and AAFP. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20610311     DOI: 10.1016/j.jfms.2010.05.004

Source DB:  PubMed          Journal:  J Feline Med Surg        ISSN: 1098-612X            Impact factor:   2.015


  10 in total

Review 1.  Five things every community pharmacist should know when dispensing for 4-legged patients.

Authors:  Grace Frankel; Alby Kusno; Christopher Louizos
Journal:  Can Pharm J (Ott)       Date:  2016-02-05

Review 2.  Feline drug metabolism and disposition: pharmacokinetic evidence for species differences and molecular mechanisms.

Authors:  Michael H Court
Journal:  Vet Clin North Am Small Anim Pract       Date:  2013-09       Impact factor: 2.093

3.  In Vitro and In Vivo Characterization of a Fully Felinized Therapeutic Anti-Nerve Growth Factor Monoclonal Antibody for the Treatment of Pain in Cats.

Authors:  D P Gearing; M Huebner; E R Virtue; K Knight; P Hansen; B D X Lascelles; R P Gearing; A C Drew
Journal:  J Vet Intern Med       Date:  2016-06-15       Impact factor: 3.333

4.  Multimodal analgesia for treatment of allodynia and hyperalgesia after major trauma in a cat.

Authors:  Mariela Goich; Alejandra Bascuñán; Patricio Faúndez; Alicia Valdés
Journal:  JFMS Open Rep       Date:  2019-06-18

5.  Lower urinary tract transitional cell carcinoma in cats: Clinical findings, treatments, and outcomes in 118 cases.

Authors:  Maureen A Griffin; William T N Culp; Michelle A Giuffrida; Peter Ellis; Joanne Tuohy; James A Perry; Allison Gedney; Cassie N Lux; Milan Milovancev; Mandy L Wallace; Jonathan Hash; Kyle Mathews; Julius M Liptak; Laura E Selmic; Ameet Singh; Carrie A Palm; Ingrid M Balsa; Philipp D Mayhew; Michele A Steffey; Robert B Rebhun; Jenna H Burton; Michael S Kent
Journal:  J Vet Intern Med       Date:  2019-11-13       Impact factor: 3.333

6.  Acute and severe haemorrhage following pentosan polysulfate injection in a Cornish Rex.

Authors:  Miranda X Tong; Jessica F Romine; Michael R Hardcastle
Journal:  JFMS Open Rep       Date:  2021-11-09

Review 7.  Drug-Dosing Adjustment in Dogs and Cats with Chronic Kidney Disease.

Authors:  Francesca De Santis; Andrea Boari; Francesco Dondi; Paolo Emidio Crisi
Journal:  Animals (Basel)       Date:  2022-01-21       Impact factor: 2.752

8.  Pamidronate disodium for palliative therapy of feline bone-invasive tumors.

Authors:  Jackie M Wypij; David A Heller
Journal:  Vet Med Int       Date:  2014-06-09

9.  Analgesic efficacy of oral firocoxib in ovariohysterectomized cats.

Authors:  Prangtip Phuwapattanachart; Naris Thengchaisri
Journal:  J Vet Sci       Date:  2017-06-30       Impact factor: 1.672

10.  Frunevetmab, a felinized anti-nerve growth factor monoclonal antibody, for the treatment of pain from osteoarthritis in cats.

Authors:  Margaret E Gruen; Jamie A E Myers; Jezaniah-Kira S Tena; Csilla Becskei; Dawn M Cleaver; B Duncan X Lascelles
Journal:  J Vet Intern Med       Date:  2021-11-01       Impact factor: 3.333

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.